SUMMARY: More navel-gazing on antibody response, and let’s leave low platelets alone; it might scare the geese.
After the great interest shown by the UK Parliament, our readers and the enablers at the MHRA, we continue reviewing the minutes of the 25 February 2021 meeting of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk …